Nephrocare Health Services Ltd

Nephrocare Health Services Ltd has issued corporate guarantees and provided collateral support for its overseas subsidiaries, Nephrocare Health Care Services Philippines Inc. (NHCSPI) and Nephrocare Health Services International Pte. Ltd. (NHSI). A corporate guarantee of USD 5,500,000 (INR 52.46 Crore) was provided to Citibank N.A. for NHCSPI's credit facilities. Additionally, collateral support was given to HSBC for NHSI's fund-based and non-fund-based credit facilities, amounting to USD 3,315,622 (INR 31.26 Crore). These transactions are undertaken in the ordinary course of business and on an arm's length basis, with no direct interest from promoters other than their shareholding in the parent company.

Nephrocare Health Services Limited's wholly-owned subsidiary in the Philippines, Nephrocare Health Care Services, Philippines Inc., has entered into an Asset Transfer Agreement (ATA) with Curis Dialysis and Kidney Care Center. The agreement, dated June 24, 2026, involves the acquisition of identified assets for a dialysis center located in Orion, Bataan, Philippines. The total consideration for this acquisition is PhP 151,600,000. This strategic move is expected to expand the company's healthcare footprint in the Philippines.

Nephrocare Health Services Limited's wholly-owned subsidiary, Nephrocare Health Services, Philippines Inc., has acquired assets of a dialysis center in Zamboanga Sibugay, Philippines, from Pag-Asa Dialysis And Diagnostic Center. The transaction, executed via an Asset Transfer Agreement dated June 22, 2026, involves a total consideration of PhP 80,640,000. This strategic acquisition aims to expand the company's footprint in the Philippine healthcare market. The seller is not related to Nephrocare or its group companies, and the transaction is not considered a related party transaction.

Nephrocare Health Services Ltd announced the approval of the NephroPlus Employee Stock Option Scheme 2026 (ESOP 2026) during its Board meeting on June 22, 2026. The scheme, recommended by the Nomination and Remuneration Committee, is in compliance with SEBI regulations and the Companies Act, 2013. It allows for the grant of up to 20,06,814 stock options, convertible into equity shares, representing approximately 2% of the company's paid-up capital. Additionally, the board approved providing collateral support of up to INR 70 Crore for its Saudi Arabian subsidiary's credit facilities, superseding a previous approval.

Nephrocare Health Services Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is effective from June 22, 2026, and will remain in effect until 48 hours after the declaration of the company's unaudited financial results for the quarter ended June 30, 2026. The measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, to prevent trading based on unpublished price-sensitive information related to the upcoming financial results. The company has also made this announcement available on its website.

Nephrocare Health Services Ltd announced that its wholly-owned subsidiary in the Philippines, Nephrocare Health Care Services, Philippines Inc., has acquired identified assets related to a dialysis center. The acquisition was made through an Asset Transfer Agreement with Amica Healthcare System Corporation for a total consideration of PhP 32,640,000. This strategic move expands the company's presence in the Philippines healthcare market.

Nephrocare Health Services Ltd announced that its wholly-owned subsidiary in the Philippines, Nephrocare Health Care Services, Philippines Inc., has entered into an Asset Transfer Agreement with Inocentes Dialysis Clinic. The agreement, dated June 04, 2026, involves the acquisition of assets related to a dialysis center in Quezon City, Philippines, for a total consideration of PHP 30,000,000. This strategic acquisition is expected to expand the company's footprint in the Philippines healthcare market.

Nephrocare Health Services International Pte. Ltd., a wholly-owned subsidiary of Nephrocare Health Services Ltd, has incorporated a new wholly-owned subsidiary in Kazakhstan named NEPHROPLUS HEALTH SERVICES KAZAKHSTAN Limited Liability Partnership (LLP) on May 26, 2026. NPHSK LLP has a charter capital of KZT 5,000,000 and aims to expand kidney care and dialysis services in Kazakhstan. The company indirectly controls 100% of NPHSK LLP.

Nephrocare Health Services Ltd's overseas step-down wholly-owned subsidiary, Nephrocare Health Services, Philippines Inc., has acquired assets pertaining to two dialysis centers in the Philippines. The acquisitions include Northern Mindanao Dialysis Clinic Inc. for PHP 27.4 million (approximately ₹4.25 Crores) and Aliaga Hemodialysis Centre Inc. for PHP 44.8 million (approximately ₹6.99 Crores). These transactions are subject to the terms and conditions outlined in the respective Asset Transfer Agreements.

Nephrocare Health Services Ltd's board approved audited financial results for FY26 and further investment of up to ₹10 Crore in its Nepalese subsidiary, Nephrocare Health Services Nepal Private Limited. It also granted in-principal approval for providing collateral/security support aggregating up to ₹70 Crore each to its Singapore and Saudi Arabia subsidiaries to enable them to avail credit facilities. M/s. BDO India LLP was re-appointed as Internal Auditor for FY 2026-27.